Blood pressure control, proteinuria, and the progression of renal disease: The modification of diet in renal disease study

Annals of Internal Medicine

Volumn 123, Issue 10, 1995, Pages 754-762

  Peterson, John C ^a,b   Adler, Sharon ^a,c   Burkart, John M ^a,d   Greene, Tom ^a,e   Hebert, Lee A ^a,f   Hunsicker, Lawrence G ^a,g   King, Andrew J ^a,h   Klahr, Saulo ^a,i   Massry, Shaul G ^a,j   Seifter, Julian L ^a,k  

^a Modification Diet Ren Dis Stud G ^*  (United States)

^b UNIVERSITY OF FLORIDA   (United States)

^c HARBOR UCLA MEDICAL CENTER   (United States)

^d WAKE FOREST SCHOOL OF MEDICINE   (United States)

^e LERNER RESEARCH INSTITUTE   (United States)

^f OHIO STATE UNIVERSITY   (United States)

^g UNIVERSITY OF IOWA HOSPITALS AND CLINICS   (United States)

^h TUFTS MEDICAL CENTER   (United States)

ⁱ BARNES JEWISH HOSPITAL   (United States)

^j UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^k BRIGHAM AND WOMEN S HOSPITAL   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; BLOOD PRESSURE REGULATION; CHRONIC KIDNEY DISEASE; DISEASE COURSE; DISEASE SEVERITY; GLOMERULUS FILTRATION RATE; HUMAN; MAJOR CLINICAL STUDY; MEAN ARTERIAL PRESSURE; PRIORITY JOURNAL; PROTEINURIA;

EID: 0028838569     PISSN: 00034819     EISSN: None     Source Type: Journal    
DOI: 10.7326/0003-4819-123-10-199511150-00003     Document Type: Article

References (32)

1. Brenner BM, Meyer TW, Hostetter TH. Dietary protein intake and the progressive nature of kidney disease: the role of hemodynamically mediated glomerular injury in the pathogenesis of progressive glomerular sclerosis in aging, renal ablation, and intrinsic renal disease. N Engl J Med. 1982;307:652-9.
2. Klahr S, Schreiner G, Ichikawa I. The progression of renal disease. N Engl J Med. 1988;318:1657-66.
3. William JD, Coles GA. Proteinuria - a direct cause of renal morbidity? Kidney Int. 1994;45:443-50.
4. Klahr S. The kidney in hypertension - villain and victim [Editorial]. N Engl J Med. 1989;320:731-3.
5. Brazy PC, Stead WW, Fitzwilliam JF. Progression of renal insufficiency: role of blood pressure. Kidney Int. 1989;35:670-4.
6. Alvestrand A, Gutierrez A, Bucht H, Bergström J. Reduction of blood pressure retards the progression of chronic renal failure in man. Nephrol Dial Transplant. 1988;3:624-31.
7. Williams PS, Fass G, Bone JM. Renal pathology and proteinuria determine progression in untreated mild/moderate chronic renal failure. Q J Med. 1988;67:343-54.
8. Apperloo AJ, deZeeuw D, deJong PE. The initial antiproteinuric effect of antihypertensive treatment predicts the effect of treatment on long-term renal function outcome [Abstract]. J Am Soc Nephrol. 1992;3: 279(A).
9. Remuzzi G, Bertani T. Is glomerulosclerosis a consequence of altered glomerular permeability to macromolecules? [Editorial] Kidney Int. 1990;38:384-94.
10. Klahr S, Levey AS, Beck GJ, Caggiula AW, Hunsicker L, Kusek JW, et al. The effects of dietary protein restriction and blood-pressure control on the progression of chronic renal disease. Modification of Diet in Renal Disease Study Group. N Engl J Med. 1994;330:877-84.
11. Beck GJ, Berg RL, Coggins CH, Gassman JJ, Hunsicker LG, Schluchter MD, et al. Design and statistical issues of the Modification of Diet in Renal Disease Trial. The Modification of Diet in Renal Disease Study Group. Control Clin Trials. 1991;12:566-86.
12. Hunsicker L, Adler S, Caggiula A, England B, Greene T, Kusek J, et al. Relationship among baseline proteinuria, mean arterial blood pressure during follow-up, and decline in glomerular filtration rate in the Modification of Diet in Renal Disease Study [Abstract]. J Am Soc Nephrol. 1993;4:254.
13. Greene T, Bourgoignie JJ, Habwe V, Kusek JW, Snetselaar LG, Soucie JM, et al. Baseline characteristics in the Modification of Diet in Renal Disease Study. J Am Soc Nephrol. 1993;4:1221-36.
14. Frisancho AR. Anthropometric Standards for the Assessment of Growth and Nutritional Status. Ann Arbor: Univ of Michigan Pr; 1990.
15. Levey AS, Adler S, Caggiula AW, England BK, Greene T, Hunsicker LG, et al. Association of increased protein intake with progression of renal disease in patients with advanced renal insufficiency [Abstract]. Proceedings of the Third Annual Spring Clinical Nephrology Meetings. National Kidney Foundation. 1994:A-14.
16. Kusek JW, Coyne T, de Velasco A, Drabik M, Finlay RA, Gassman JJ, et al. Recruitment experience in the full-scale phase of the Modification of Diet in Renal Disease Study. Control Clin Trials. 1993;14:538-57.
17. The fifth report of the Joint National Committee on Detection, Evaluation, and Treatment of High Blood Pressure (JNC V). Arch Intern Med. 1993;153:154-83.
18. 99mTc-DTPA, and inulin. The Modification of Diet in Renal Disease Study. Am J Kidney Dis. 1990;16:224-35.
19. Levey AS, Greene T, Schluchter MD, Cleary PA, Teschan PE, Lorenz RA, et al. Glomerular filtration rate measurements in clinical trials. Modification of Diet in Renal Disease Study Group and the Diabetes Control and Complications Trial Research Group. J Am Soc Nephrol. 1993;4:1159-71.
20. Maroni BJ, Steinman TL, Mitch WE. A method for estimating nitrogen intake of patients with chronic renal failure. Kidney Int. 1985;27: 58-65.
21. Pesce MA, Strande CS. A new micromethod for determination of protein in cerebrospinal fluid and urine. Clin Chem. 1973;19:1265-7.
22. Laird NM, Ware JH. Random-effects models for longitudinal data. Biometrics. 1982;38:963-74.
23. Schluchter MD. Methods for the analysis of informatively censored longitudinal data. Stat Med. 1992;11:1861-70.
24. Lazarus J, Buckalew V, Bourgoignie J, Greene T, Milas C, Paranandi L, et al. Blood pressure compliance and safety in the MDRD Study [Abstract]. Proceedings of the Third Annual Spring Clinical Nephrology Meetings. National Kidney Foundation. 1994:A-4.
25. Parving HH, Andersen AR, Hommel E, Smidt U. Effects of long-term antihypertensive treatment on kidney function in diabetic nephropathy. Hypertension. 1985;7(6 Pt 2):II114-7.
26. Parving HH, Andersen AR, Smidt UM, Hommel E, Mathiesen ER, Svendsen PA. Effect of antihypertensive treatment on kidney function in diabetic nephropathy. BMJ (Clin Res Ed). 1987;294:1443-7.
27. Praga M, Hernandez E, Montoyo C, Andres A, Ruilope LM, Rodicio JL. Long-term beneficial effects of angiotensin-converting enzyme inhibition in patients with nephrotic proteinuria. Am J Kidney Dis. 1992; 20:240-8.
28. Stenvinkel P, Alvestrand A, Bergström J. Factors influencing progression in patients with chronic renal failure. J Intern Med. 1989;226: 183-8.
29. Gordge MP, Leaker BR, Rylance PB, Neild GH. Haemostatic activation and proteinuria as factors in the progression of chronic renal failure. Nephrol Dial Transplant. 1991;6:21-6.
30. Hunt LP, Short CD, Mallick NP. Prognostic indicators in patients presenting with the nephrotic syndrome. Kidney Int. 1988;34:382-8.
31. Williams PS, Fass G, Bone JM. Renal pathology and proteinuria determine progression in untreated mild/moderate chronic renal failure. Q J Med. 1988;67:343-54.
32. Perrone RD. Means of clinical evaluation of renal disease progression. Kidney Int Suppl. 1992;36:S26-32.